Batory Foods has announced the launch of a new business unit called Batory Sweetener Solutions, following its acquisition of the Savannah-based Sweetener Solutions in early 2022.
Batory Foods (Rosemont, IL) has announced the launch of a new business unit called Batory Sweetener Solutions, following its acquisition of the Savannah-based Sweetener Solutions in early 2022. Batory explains that the business unit will be dedicated to all initiatives surrounding food and beverage sweeteners, from conventional ingredients and low-sugar alternatives to precision blending and custom formulations.
“Through Batory Sweetener Solutions, Batory Foods is eager to support customers in making a meaningful impact on healthier food and beverage products through more and better-tasting lower-sugar options,” said Vince Pinneri, president of Batory Foods, in a press release. “As a prominent and ever-growing player in the sweeteners and sugar reduction spaces, we see it as our corporate responsibility to help alleviate a substantial public health problem, while supporting our customers to offer great products to their consumers.”
Batory Sweetener Solutions will be led by Jessica Zielinski, who spent the previous two years as Batory Foods’ director of sales. Zielinski has extensive experience in the food ingredients sector, including an upwardly mobile tenure with Tate & Lyle that lasted a decade.
“Our exponential growth in the sweeteners space over the past few years brought us to this very satisfying place – one where our sweeteners capabilities called for its own dedicated cornerstone of our business,” added Pinneri. “As Batory Sweetener Solutions launches and matures, we will continue to broaden our ingredient offerings and capabilities in the sweetener realm, aligning with key consumer trends in sugar reduction and replacement – all while meeting mounting sugar consumption concerns with innovative, palate-pleasing solutions.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.